Seoul Pharma Co. Ltd (018680) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.064x

Based on the latest financial reports, Seoul Pharma Co. Ltd (018680) has a cash flow conversion efficiency ratio of -0.064x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.66 Billion ≈ $-1.80 Million USD) by net assets (₩41.30 Billion ≈ $27.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 018680 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Seoul Pharma Co. Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Seoul Pharma Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Seoul Pharma Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Seoul Pharma Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Olympia Industries Bhd KLSE:3018	0.024x
PYRAMID AG NA O.N. XETRA:M3B	0.092x
Nacon Sa PA:NACON	0.040x
Indian Terrain Fashions Limited NSE:INDTERRAIN	0.029x
Trailblazer Merger Corporation I Class A Common Stock NASDAQ:TBMC	0.038x
Trivarx Ltd AU:TRI	-0.023x
Volt Power Group Ltd AU:VPR	0.043x
bet-at-home.com AG F:ACX	0.301x

Annual Cash Flow Conversion Efficiency for Seoul Pharma Co. Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Seoul Pharma Co. Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 018680 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩40.17 Billion ≈ $27.22 Million	₩-3.01 Billion ≈ $-2.04 Million	-0.075x	-154.86%
2023-12-31	₩38.56 Billion ≈ $26.13 Million	₩5.26 Billion ≈ $3.57 Million	0.137x	+6282.46%
2022-12-31	₩35.42 Billion ≈ $24.00 Million	₩-78.21 Million ≈ $-53.01K	-0.002x	+97.50%
2021-12-31	₩18.96 Billion ≈ $12.85 Million	₩-1.67 Billion ≈ $-1.13 Million	-0.088x	-144.43%
2020-12-31	₩28.85 Billion ≈ $19.55 Million	₩5.74 Billion ≈ $3.89 Million	0.199x	+93.15%
2019-12-31	₩28.45 Billion ≈ $19.28 Million	₩2.93 Billion ≈ $1.98 Million	0.103x	+522.01%
2018-12-31	₩50.31 Billion ≈ $34.10 Million	₩-1.23 Billion ≈ $-831.74K	-0.024x	-15.51%
2017-12-31	₩53.86 Billion ≈ $36.50 Million	₩-1.14 Billion ≈ $-770.77K	-0.021x	+53.00%
2016-12-31	₩42.07 Billion ≈ $28.51 Million	₩-1.89 Billion ≈ $-1.28 Million	-0.045x	-205.98%
2015-12-31	₩33.53 Billion ≈ $22.72 Million	₩1.42 Billion ≈ $963.32K	0.042x	-10.82%
2014-12-31	₩31.10 Billion ≈ $21.08 Million	₩1.48 Billion ≈ $1.00 Million	0.048x	+460.77%
2013-12-31	₩32.25 Billion ≈ $21.86 Million	₩-425.00 Million ≈ $-288.02K	-0.013x	-103.63%
2012-12-31	₩25.38 Billion ≈ $17.20 Million	₩9.22 Billion ≈ $6.25 Million	0.363x	--

About Seoul Pharma Co. Ltd

KQ:018680 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$17.98 Million

₩26.52 Billion KRW

Market Cap Rank

#25475 Global

#1846 in Korea

Share Price

₩2275.00

Change (1 day)

-5.99%

52-Week Range

₩2170.00 - ₩3445.00

All Time High

₩17976.69